Shanghai Yingrui Biopharma Co., Ltd.

News

Company newsmore +

2019 CPHI China is successfully ended!

2019-06-25

Congratulations on the success of the new website of Yin

2019-06-25

2019 CPHI China is successfully ende

2019-06-25

Congratulations on the success of th

2019-06-25

Industry newsmore +

Sesen Bio Inc. Publishes Data on Phase III Clinical Stud

2019-08-23

Three companies collaborated to evaluate the efficacy of

2019-07-24

NMPA Approves Halaven as a New Anticancer Drug for Local

2019-07-24

Shortage of cheap drugs has eased this year. Most of the

2019-06-26

China's medical sector will usher in a major shuffle!

2019-06-26

Sesen Bio Inc. Publishes Data on Pha

2019-08-23

Three companies collaborated to eval

2019-07-24

NMPA Approves Halaven as a New Antic

2019-07-24

Shortage of cheap drugs has eased th

2019-06-26

China's medical sector will usher i

2019-06-26

Copyright © 2017-2020 SHANGHAI YINGRUI BIOPHARMA CO.,LTD 沪ICP备11038445号-1
TEL：+86-21-33585366(DDT)、34666753 FAX：+86-21-34979012
E-mail：info@bideaua.com ADD：1885 Metropolitan Road, Minhang District, Shanghai Code：201108